Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant (YPT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by University of California, Los Angeles
Sponsor:
Collaborator:
University of Rhode Island
Information provided by (Responsible Party):
Dr. Amy D. Waterman, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT02181114
First received: June 27, 2014
Last updated: July 2, 2014
Last verified: July 2014
  Purpose

Because of the deceased donor organ shortage, more kidney patients are considering whether to receive kidneys from family and friends, a process called living donor kidney transplantation (LDKT). Although Blacks are 3.4 times more likely to develop end stage renal disease, they are less likely to receive LDKTs. To address this disparity, this randomized controlled trial will assess whether Black and White transplant patients' knowledge and receipt of LDKTs can be increased when they receive access to the Your Path to Transplant computerized Expert System (YPT). This trial will also examine how other known patient, family, and healthcare system barriers to LDKT impact YPT's effectiveness.

Nine hundred (900) Black and White ESRD patients presenting for transplant medical evaluation at University of California-Los Angeles Kidney and Pancreas Transplant Program (UCLA-KPTP) in Los Angeles, California will be stratified by race and randomly assigned to one of two education conditions (YPT vs. Usual Care Education). As they undergo transplant evaluation, patients in the YPT condition will receive individually-tailored feedback reports, coaching, and socioeconomic resource guidance associated with reducing barriers to access to LDKT. Control patients will receive usual care transplant education provided by UCLA-KPTP. Changes in knowledge, readiness to pursue LDKT, pros/cons to LDKT, and self-efficacy will be assessed at four time points: prior to presenting at the transplant center (baseline), during transplant evaluation (approximately 2 months post-baseline), and 4- and 8-months post-baseline. Completion of transplant evaluation and receipt of LDKTs will be assessed 18-months post-baseline.

At the conclusion of the study, we will have developed an innovative and cost-effective YPT Computerized Expert System that could be utilized to tailor LDKT discussion and education in different medical settings based on the needs of individual patients of different races.


Condition Intervention
End Stage Renal Disease
Behavioral: Expert System Coaching

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research

Resource links provided by NLM:


Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:
  • Patient LDKT Attitude & Decision-Making Measure: Demographics and Personality Variables [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Demographic information for patients will be collected via survey questions that assess the patient's age, gender, ethnicity distance from the transplant center, type of health insurance received, and education and income levels.

  • Patient LDKT Attitude & Decision Making Measure: Transplant Knowledge [ Time Frame: up to 8 months post-Baseline ] [ Designated as safety issue: No ]
    Patients will be asked 11 true/false and 8 multiple choice questions to determine their level of knowledge regarding basic facts, advantages, risks and outcomes of DDKT and LDKT (e.g., Patients older than 80 years can receive transplants (true); Compared to transplants from donors who have died, how long do transplants from living donors last?)

  • Patient LDKT Attitude & Decision Making Measure: LDKT Readiness and Offers [ Time Frame: up to 8 months post-Baseline ] [ Designated as safety issue: No ]
    Patients will report whether they are either "not considering getting a living donor transplant in the next six months" (Precontemplation), "considering taking actions to get a living donor transplant in the next six months" (Contemplation), "preparing to take actions to get a living donor transplant in the next 30 days" (Preparation), or "taking actions to get a living donor transplant" (Action). Patients will also be asked if they have family members and friends who might consider being living donors (yes/no) and how many living donors have offered to be evaluated, undergone evaluation, been ruled out, or matched them

  • Patient LDKT Attitude & Decision Making Measure:Decisional Balance [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    A Decisional Balance measure provides information about the relative importance an individual places on possible LDKT positive and negative outcomes (e.g., "The surgery would be too painful or stressful for the donor"; "Most living donors say they are very glad they donated and would do it again"). Patients will be asked to rate the importance of each statement on a 5-point scale ranging from, (1) "Not important" to (5) "Extremely important."

  • Patient LDKT Attitude & Decision Making Measure:Self-Efficacy [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    The Self-Efficacy scale measures the confidence an individual has in his or her ability to pursue an LDKT in a wide variety of challenging situations (e.g., "If Your friends and family were unsupportive of you getting a transplant") on a scale from (1) "Not at all confident" to (5) "Completely confident."


Estimated Enrollment: 900
Study Start Date: May 2014
Estimated Study Completion Date: September 2016
Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Expert System Coaching
Patients in the intervention group will receive coaching based off the answers provided in the computer-based Expert System that is designed to track their readiness level to pursue a living donor kidney transplant
Behavioral: Expert System Coaching
No Intervention: Control
Patients in the control group will only receive the standard of care education that is offered at the UCLA Kidney and Pancreas Transplant Center which consists of a powerpoint presentation on their Evaluation Day appointment.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Self-identify as White or African-American
  • Can not be a prior kidney recipient
  • Must not have been deemed kidney transplant ineligible by UCLA Kidney and Pancreas Transplant Program
  • Cannot be listed at another transplant center
  • Can read English

Exclusion Criteria:

  • Does not self-identify as White or African-American
  • Received a kidney transplant prior
  • Deemed ineligible to receive a kidney transplant by UCLA Kidney and Transplant Program
  • Listed at another transplant center
  • Cannot read English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02181114

Contacts
Contact: Crystal S Kynard-Amerson, MPH 310-206-7243 ckynard@mednet.ucla.edu
Contact: John D Peipert, MA, MSW 310-206-4750 jpeipert@mednet.ucla.edu

Locations
United States, California
UCLA Division of Nephrology Recruiting
Los Angeles, California, United States, 90024
Contact: Crystal S Kynard-Amerson, MPH    310-206-7243    ckynard@mednet.ucla.edu   
Principal Investigator: Amy D Waterman, PhD         
United States, Rhode Island
University of Rhode Island Recruiting
Kingston, Rhode Island, United States, 02881
Contact: Mark Robbins, PhD    401-874-5082    markrobb@uri.edu   
Sub-Investigator: Mark Robbins, PhD         
Sponsors and Collaborators
University of California, Los Angeles
University of Rhode Island
  More Information

No publications provided by University of California, Los Angeles

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr. Amy D. Waterman, Associate Professor in Residence, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT02181114     History of Changes
Obsolete Identifiers: NCT01553864
Other Study ID Numbers: DK088711-1
Study First Received: June 27, 2014
Last Updated: July 2, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Los Angeles:
Coaching
Educational Materials
Expert System
Living Donor Kidney Transplant

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases

ClinicalTrials.gov processed this record on November 27, 2014